Novavax
NVAX
129 hedge funds and large institutions have $588M invested in Novavax in 2013 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 35 reducing their positions, and 21 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
76% more capital invested
Capital invested by funds: $334M → $588M (+$254M)
60% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 35
24% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 21
4% more funds holding
Funds holding: 124 → 129 (+5)
61% less call options, than puts
Call options by funds: $3M | Put options by funds: $7.75M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$25M |
| 2 |
State Street
Boston,
Massachusetts
|
+$16.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.5M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.44M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$4.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$35.3M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$4.47M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$4.28M |
| 4 |
DM
Deerfield Management
New York
|
-$3.39M |
| 5 |
WHI
William Harris Investors
Chicago,
Illinois
|
-$3.28M |
NVAX Hedge Fund Activity: Q4 2013 in Review
129 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2013, worth a combined $588M — up 76% from $334M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new NVAX positions and 21 closed out — a net gain of 5 holders — while 56 added to existing stakes and 35 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $25M. The largest seller was RA Capital Management, cutting an estimated $35.3M.
- 129 institutional investors held Novavax (NVAX) as of Q4 2013, up from 124 in Q3 2013.
- Funds reported $588M of Novavax stock for Q4 2013, up 76% quarter-over-quarter.
- 26 funds opened new Novavax positions in Q4 2013 and 21 closed out, a net change of +5 holders.
- The largest Novavax buyer in Q4 2013 was Invesco, an estimated $25M added.
- The largest Novavax seller in Q4 2013 was RA Capital Management, an estimated $35.3M sold.
Based on aggregated 13F filings for Q4 2013.